TransCode Therapeutics, Inc., (RNAZ) Social Stream
TRANSCODE THERAPEUTICS INC (RNAZ) Price Targets From Analysts
Use the tables below to see what analysts covering TRANSCODE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-16 | 1 | $10 | $10 | $10 | $0.159 | 6189.31% |
| 2022-11-15 | 1 | $120 | $120 | $120 | $0.159 | 75371.7% |
| 2023-08-15 | 1 | $12 | $12 | $12 | $0.159 | 7447.17% |
| 2023-12-06 | 1 | $3 | $3 | $3 | $0.159 | 1786.79% |
Price Target Last Issued December 6, 2023
RNAZ reports an average of 778.98% for its upside potential over the past 160 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-29 | 1 | 12 | 12 | 12 | 2.420 | 395.87% |
| 2023-08-15 | 1 | 12 | 12 | 12 | 1.620 | 640.74% |
| 2023-10-25 | 1 | 3 | 3 | 3 | 0.371 | 708.63% |
| 2023-11-15 | 1 | 3 | 3 | 3 | 0.287 | 945.3% |
| 2023-12-06 | 1 | 3 | 3 | 3 | 0.230 | 1204.35% |
RNAZ Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
Over the past 18 months, RNAZ's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RNAZ as an investment opportunity.
- In the context of all US stocks, TRANSCODE THERAPEUTICS INC's number of analysts covering the stock is higher than nearly none of them.
- To contextualize these metrics, consider that out of all US stocks, TRANSCODE THERAPEUTICS INC's variance in analysts' estimates is lower than nearly 100% of them.
- In terms of how TRANSCODE THERAPEUTICS INC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 491.44% of that group.
- In the context of Healthcare stocks, TRANSCODE THERAPEUTICS INC's average analyst price target is greater than 131.44% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TRANSCODE THERAPEUTICS INC are UNCY, DRMA, and CVKD.
View All Top Stocks by Price Target
Is RNAZ a Buy, Hold or Sell? See the POWR Ratings now!